ImageneBio (IMA) Net Cash Flow (2020 - 2024)
Historic Net Cash Flow for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$74.1 million.
- ImageneBio's Net Cash Flow fell 525668.84% to -$74.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$80.9 million, marking a year-over-year decrease of 44606.7%. This contributed to the annual value of -$80.9 million for FY2024, which is 23399.41% down from last year.
- According to the latest figures from Q4 2024, ImageneBio's Net Cash Flow is -$74.1 million, which was down 525668.84% from $68.8 million recorded in Q3 2024.
- ImageneBio's 5-year Net Cash Flow high stood at $118.5 million for Q1 2021, and its period low was -$185.3 million during Q1 2022.
- For the 5-year period, ImageneBio's Net Cash Flow averaged around -$3.9 million, with its median value being -$7.7 million (2020).
- In the last 5 years, ImageneBio's Net Cash Flow soared by 128875.63% in 2021 and then tumbled by 525668.84% in 2024.
- Quarter analysis of 5 years shows ImageneBio's Net Cash Flow stood at $106.6 million in 2020, then plummeted by 112.83% to -$13.7 million in 2021, then surged by 47.71% to -$7.2 million in 2022, then surged by 80.67% to -$1.4 million in 2023, then tumbled by 5256.69% to -$74.1 million in 2024.
- Its last three reported values are -$74.1 million in Q4 2024, $68.8 million for Q3 2024, and -$8.6 million during Q2 2024.